Intelligent Bio Solutions Inc. (INBS) Announces UK-Wide Glass Manufacturer to Roll Out Non-Invasive Drug Screening System Across UK Operations
07 nov. 2022 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company developing non-invasive, real-time diagnostic testing for patients...
Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing
03 nov. 2022 08h30 HE
|
Intelligent Bio Solutions, Inc.
- Eastern Airways to use portable, hygienic, non-invasive fingerprint sweat test to support new European Aviation Authority regulations - NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio...
Intelligent Bio Solutions Inc. to Present First Quarter 2023 Financial Results and Recent Corporate Update on November 9
02 nov. 2022 16h05 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions,...
GBS Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights
10 mai 2022 16h05 HE
|
GBS Inc.
- Initiated prospective study to collect coincident samples of oral fluid and blood following IRB approval - - Finalizing site selection at the University of Newcastle campus for the high-tech...
GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
10 févr. 2022 16h05 HE
|
GBS Inc.
- Discussions underway between the University of Newcastle and GBS to oversee the high-tech manufacturing facility supported by its $4.7 Million Grant Funding Award from Australian Government - -...
GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
11 nov. 2021 16h05 HE
|
GBS Inc.
– Announced Pre-Submission Package sent to the FDA for its Glucose Biosensor Test – – Clinical Validation Study Results for SARS CoV2 Ab Test – – Evaluating site locations for build out of...
GBS Inc. to Present First Quarter 2022 Financial Results and Recent Corporate Update on November 11
01 nov. 2021 16h05 HE
|
GBS Inc.
NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...
GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
01 nov. 2021 08h00 HE
|
GBS Inc.
NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...
GBS Inc. Announces its Pre-Submission package is with the FDA
13 oct. 2021 08h30 HE
|
GBS Inc.
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at...
GBS Inc. to Present at Upcoming September Virtual Investor Conferences
07 sept. 2021 16h05 HE
|
GBS Inc.
H.C. Wainwright 23rd Global Investor Conference: September 13th - 15th Benzinga Healthcare Small Cap Conference: September 29th - 30th NEW YORK, Sept. 07, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq:...